Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression (Q45858579)

17 December 2017

title

Early exposure of high-dose interleukin-4 to tumor stroma reverses myeloid cell-mediated T-cell suppression (English)

1 reference

17 December 2017

author name string

J Jiang

1

1 reference

17 December 2017

Z Wang

2

1 reference

17 December 2017

Z Li

3

1 reference

17 December 2017

J Zhang

4

1 reference

17 December 2017

C Wang

5

1 reference

17 December 2017

X Xu

6

1 reference

17 December 2017

Z Qin

7

1 reference

17 December 2017

publication date

22 April 2010

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

17

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

991-999

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2010.54

exact match

0 references

cites work

Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

The terminology issue for myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Inhibition of tumor growth by elimination of granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

IL-4-transfected tumor cell vaccines activate tumor-infiltrating dendritic cells and promote type-1 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

The IL-4 receptor: signaling mechanisms and biologic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Regulatory T cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Regulatory T cells and immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Genetic dissection of consolidated memory in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

B-cell stimulatory factor-1/interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Tumor Rejection by Modulation of Tumor Stromal Fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Inhibition of angiogenesis by interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Cross-talk between T cells and innate immune cells is crucial for IFN-gamma-dependent tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

7 January 2021

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

7 January 2021

Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

7 January 2021

Phase I trial of intravenous IL-4 pseudomonas exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

7 January 2021

Tumor necrosis factor receptor 2-mediated tumor suppression is nitric oxide dependent and involves angiostasis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.54

7 January 2021

Identifiers

DOI

10.1038/GT.2010.54

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017